Humapen Memoir

Eli Lilly and Co., is introducing a new innovative insulin pen designed to help diabetics make fewer mistakes with their insulin doses. Lilly, which already produces the Humalog insulin product, is now set to offer the Humapen Memoir, which electronically records the time and amount of multiple doses. The device, which resembles a pen, will be for diabetics who take Humalog. Patients will be able to look back at their last few doses, because it goes back to two to three days of insulin dosing. The device will hit the market on Feb. 1

If you would like more information about this product, complete the following.